工程化介质干细胞:一种用于 Th2 向调节的新方法,用于过敏性喘
Mahdi Tabasheri1, Amir Mahdi Mahdavi1, Forough Parhizkar2
1Student Research Committee, School of Medicine, Zanjan University of Medical Sciences, Zanjan, Iran.
Allergologia et immunopathologia
|November 13, 2025
概括
介酶干细胞 (MSCs) 通过调节免疫反应来治疗高Th2的喘. 工程化MSC提供了更高的疗效和更好的治疗潜力,用于喘管理.
科学领域:
- 免疫学 免疫学 免疫学
- 过敏研究 研究过敏
- 再生医学是一种再生医学.
背景情况:
- 喘在全球影响3亿人,T-helper2 (Th2) 细胞驱动的炎症是关键因素.
- 介酶干细胞 (MSCs) 为喘提供了一种新的治疗途径,与传统治疗不同.
- 了解Th2高喘的机制对于开发向治疗至关重要.
研究的目的:
- 审查目前对Th2高喘的理解.
- 探索中干细胞 (MSCs) 作为喘治疗方法.
- 讨论工程MSCs的潜力,以改善喘管理.
主要方法:
- 关于喘分类和发病因子的文献综述.
- 分析MSC机制调节与喘相关的免疫反应.
- 探索基因工程策略,以增强MSC的治疗特性.
主要成果:
- MSCs通过分泌物和细胞相互作用发挥治疗作用,影响树突细胞和巨细胞.
- 传统的MSC治疗存在挑战,包括指导和生存.
- 改造后的MSC证明了对喘控制的指导,生存和免疫调节的改进.
结论:
- MSCs为Th2高喘提供了一个有前途的治疗策略.
- 工程MSC通过向Th2细胞和减少炎症,提供更高的疗效.
- 进一步开发工程MSC可以显著改善喘管理和患者的治疗结果.
更多相关视频
10:10Development of Stem Cell-derived Antigen-specific Regulatory T Cells Against Autoimmunity
Published on: November 8, 2016
9.2K
10:39Advanced Imaging of Lung Homing Human Lymphocytes in an Experimental In Vivo Model of Allergic Inflammation Based on Light-sheet Microscopy
Published on: April 16, 2019
8.1K
相关概念视频
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
1.7K
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
1.7K
Mesenchymal Stem Cells
5.5K
Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
5.5K
Antiasthma Drugs: Leukotriene Modifiers
1.7K
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
1.7K
Asthma: Pathogenesis and Management
1.2K
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.2K
Asthma-II: Pathophysiology and Classification
4.0K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
4.0K
